Back
Invesco Emerging Markets Sov Debt ETF Vs. Avidity Biosciences Industry Stock Comparison
Buy
51
PCY
Invesco Emerging Markets Sov Debt ETF
Last Price:
20.36
Seasonality Move:
0.62%
Sell
28
RNA
Avidity Biosciences
Last Price:
42.16
Seasonality Move:
39.98%
Buy
51
Invesco Emerging Markets Sov Debt ETF (PCY)
is a Buy
Is Invesco Emerging Markets Sov Debt ETF a Buy, Sell or Hold?
- The current Invesco Emerging Markets Sov Debt ETF [PCY] share price is $20.35. The Score for PCY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PCY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PCY Stock Price Chart
What is Invesco Emerging Markets Sov Debt ETF's stock price today?
-
The Invesco Emerging Markets Sov Debt ETF share price today is $20.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCY is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $42.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
PCY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 37.36 | Sell |
Chaikin Money Flow: | -182522 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.43 - 20.95) | Sell |
Bollinger Bands (100): | (20.37 - 21.21) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.53 | Buy |
Relative Strength Index (14 RSI): | 42.17 | Sell |
Chaikin Money Flow: | -1839481 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.78 - 48.76) | Sell |
Bollinger Bands (100): | (41.56 - 46.96) | Sell |
PCY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.58 | Sell |
20-day SMA: | 20.57 | Sell |
50-day SMA: | 21.01 | Sell |
200-day SMA: | 20.49 | Sell |
8-day EMA: | 20.52 | Sell |
20-day EMA: | 20.64 | Sell |
50-day EMA: | 20.8 | Sell |
200-day EMA: | 20.48 | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.51 | Sell |
20-day SMA: | 45.87 | Sell |
50-day SMA: | 45.1 | Sell |
200-day SMA: | 34.2 | Buy |
8-day EMA: | 46.84 | Sell |
20-day EMA: | 46.32 | Sell |
50-day EMA: | 45.24 | Sell |
200-day EMA: | 35.58 | Buy |
Invesco Emerging Markets Sov Debt ETF Earnings Growth & PCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.
Invesco Emerging Markets Sov Debt ETF Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |